Skip Navigation

Cardiovascular Research 2006 70(2):346-353; doi:10.1016/j.cardiores.2006.02.020
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Abdallah, Y.
Right arrow Articles by Schäfer, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abdallah, Y.
Right arrow Articles by Schäfer, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2006, European Society of Cardiology

Insulin protects cardiomyocytes against reoxygenation-induced hypercontracture by a survival pathway targeting SR Ca2+ storage

Yaser Abdallah*, Anna Gkatzoflia, Dragan Gligorievski, Sascha Kasseckert, Gerhild Euler, Klaus-Dieter Schlüter, Matthias Schäfer, Hans-Michael Piper and Claudia Schäfer

Institute of Physiology, Justus-Liebig-University, D-35392 Giessen, Germany

* Corresponding author. Physiologisches Institut, Justus-Liebig-Universität, Aulweg 129, D-35392 Giessen, Germany. Tel.: +49 6419947241; fax: +49 6419947219. Email address: yaser.abdallah{at}physiologie.med.uni-giessen.de

Objective Experimental and clinical studies have shown that administration of insulin during reperfusion is cardioprotective, but the underlying mechanisms are still unknown. In this study, we investigated in isolated rat cardiomyocytes subjected to hypoxia and reoxygenation whether administration of insulin during reoxygenation reduces reoxygenation-induced hypercontracture, a hallmark of acute reperfusion injury. The effects of insulin on potential pro-survival kinases, i.e., PI 3-kinase, NO synthase (eNOS), and cGMP-dependent protein kinase (PKG), and on cytosolic Ca2+ control in reoxygenated cardiomyocytes were investigated.

Results Administration of insulin (10mU/L) during reoxygenation protected cardiomyocytes against hypercontracture development (cell length as % of end-hypoxic length: control 61.6±3.2; insulin 76.3±2.9*; n=26; *p<0.05 vs. control). Cytosolic [Ca2+] recovery during the first 2min of reoxygenation was accelerated (fura-2 ratio after 2min of reoxygenation; control 1.01±0.05; insulin 0.79±0.04*; n=26; *p<0.05 vs. control). The beneficial effects of insulin on cytosolic [Ca2+] recovery and hypercontracture were suppressed in the presence of inhibitors of PI 3-kinase (LY294002, 1µM), eNOS (L-NMMA, 100µM), PKG (KT 5823, 1µM), or sarcoplasmic reticulum Ca2+ pump (SERCA) (thapsigargin, 150nM). Insulin increased phosphorylation and activity of eNOS and augmented phospholamban phosphorylation in reoxygenated cardiomyocytes. Correlated with phospholamban phosphorylation, insulin also augmented SR Ca2+ load.

Conclusions Insulin protects cardiomyocytes against reoxygenation-induced hypercontracture. This is due to acceleration of cytosolic [Ca2+] recovery by enhanced Ca2+ sequestration into the sarcoplasmic reticulum via SERCA activation. This protective mechanism is activated through the survival pathway consisting of PI 3-kinase, eNOS, and PKG.

KEYWORDS Insulin; Calcium; Cardiomyocytes


* Gerd Heusch, Universitätsklinikum Essen, handled this article as Guest Editor.

Time for primary review 19 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Ruiz-Meana, A. Abellan, E. Miro-Casas, E. Agullo, and D. Garcia-Dorado
Role of sarcoplasmic reticulum in mitochondrial permeability transition and cardiomyocyte death during reperfusion
Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1281 - H1289.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. J. Hausenloy and D. M. Yellon
Cardioprotective growth factors
Cardiovasc Res, July 15, 2009; 83(2): 179 - 194.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Inserte, J. A. Barrabes, V. Hernando, and D. Garcia-Dorado
Orphan targets for reperfusion injury
Cardiovasc Res, July 15, 2009; 83(2): 169 - 178.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Garcia-Dorado, M. Ruiz-Meana, and H. M. Piper
Lethal reperfusion injury in acute myocardial infarction: facts and unresolved issues
Cardiovasc Res, July 15, 2009; 83(2): 165 - 168.
[Full Text] [PDF]


Home page
Circ. Res.Home page
P. Nicolaou, P. Rodriguez, X. Ren, X. Zhou, J. Qian, S. Sadayappan, B. Mitton, A. Pathak, J. Robbins, R. J. Hajjar, et al.
Inducible Expression of Active Protein Phosphatase-1 Inhibitor-1 Enhances Basal Cardiac Function and Protects Against Ischemia/Reperfusion Injury
Circ. Res., April 24, 2009; 104(8): 1012 - 1020.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
I. Tastan, R. Schreckenberg, S. Mufti, Y. Abdallah, H. M. Piper, and K.-D. Schluter
Parathyroid hormone improves contractile performance of adult rat ventricular cardiomyocytes at low concentrations in a non-acute way
Cardiovasc Res, April 1, 2009; 82(1): 77 - 83.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. F. Dias-Peixoto, R. A.S. Santos, E. R.M. Gomes, M. N.M. Alves, P. W.M. Almeida, L. Greco, M. Rosa, B. Fauler, M. Bader, N. Alenina, et al.
Molecular Mechanisms Involved in the Angiotensin-(1-7)/Mas Signaling Pathway in Cardiomyocytes
Hypertension, September 1, 2008; 52(3): 542 - 548.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. M. Piper, Y. Abdallah, S. Kasseckert, and K.-D. Schluter
Sarcoplasmic reticulum-mitochondrial interaction in the mechanism of acute reperfusion injury
Cardiovasc Res, January 15, 2008; 77(2): 234 - 236.
[Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. Ferdinandy, R. Schulz, and G. F. Baxter
Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning
Pharmacol. Rev., December 1, 2007; 59(4): 418 - 458.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. M. Yellon and D. J. Hausenloy
Myocardial Reperfusion Injury
N. Engl. J. Med., September 13, 2007; 357(11): 1121 - 1135.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Murphy and C. Steenbergen
Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury
Cardiovasc Res, August 1, 2007; 75(3): 478 - 486.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Garcia-Dorado, J. Vinten-Johansen, and H. M. Piper
Bringing preconditioning and postconditioning into focus
Cardiovasc Res, May 1, 2006; 70(2): 167 - 169.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. M. Piper, S. Kasseckert, and Y. Abdallah
The sarcoplasmic reticulum as the primary target of reperfusion protection
Cardiovasc Res, May 1, 2006; 70(2): 170 - 173.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.